[go: up one dir, main page]

MX2007013084A - Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion. - Google Patents

Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion.

Info

Publication number
MX2007013084A
MX2007013084A MX2007013084A MX2007013084A MX2007013084A MX 2007013084 A MX2007013084 A MX 2007013084A MX 2007013084 A MX2007013084 A MX 2007013084A MX 2007013084 A MX2007013084 A MX 2007013084A MX 2007013084 A MX2007013084 A MX 2007013084A
Authority
MX
Mexico
Prior art keywords
pyridines
producing
composition containing
substituted pyrrolo
pyrrolo
Prior art date
Application number
MX2007013084A
Other languages
English (en)
Inventor
Fabrice Viviani
Michel Tabart
Frank Halley
Catherine Souaille
Pascal Desmazeau
Eric Bacque
Baptiste Ronan
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MX2007013084A publication Critical patent/MX2007013084A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion, y utilizacion. La presente invencion se refiere particularmente a la preparacion de pirrolopiridinas sustituidas, composiciones que las contienen, su proceso de preparacion, y su utilizacion como medicamento, en particular en tanto como agentes anticancerosos.
MX2007013084A 2005-04-26 2006-04-26 Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion. MX2007013084A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504173A FR2884821B1 (fr) 2005-04-26 2005-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000925 WO2006114520A2 (fr) 2005-04-26 2006-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
MX2007013084A true MX2007013084A (es) 2008-01-11

Family

ID=35517344

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007013084A MX2007013084A (es) 2005-04-26 2006-04-26 Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion.

Country Status (33)

Country Link
US (1) US7947706B2 (es)
EP (1) EP1877409B1 (es)
JP (1) JP2008539211A (es)
KR (1) KR20080007229A (es)
CN (1) CN101166739A (es)
AR (1) AR061386A1 (es)
AT (1) ATE433976T1 (es)
AU (1) AU2006239105A1 (es)
BR (1) BRPI0613161A2 (es)
CA (1) CA2605744A1 (es)
CR (1) CR9463A (es)
CY (1) CY1109369T1 (es)
DE (1) DE602006007337D1 (es)
DK (1) DK1877409T3 (es)
DO (1) DOP2006000096A (es)
EA (1) EA012983B1 (es)
ES (1) ES2328629T3 (es)
FR (1) FR2884821B1 (es)
GT (1) GT200600174A (es)
HR (1) HRP20090494T1 (es)
IL (1) IL186523A0 (es)
MA (1) MA29480B1 (es)
MX (1) MX2007013084A (es)
NO (1) NO20075918L (es)
PA (1) PA8671301A1 (es)
PE (1) PE20071420A1 (es)
PL (1) PL1877409T3 (es)
PT (1) PT1877409E (es)
RS (1) RS51136B (es)
SI (1) SI1877409T1 (es)
TN (1) TNSN07360A1 (es)
TW (1) TW200718701A (es)
WO (1) WO2006114520A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
GEP20135728B (en) * 2006-10-09 2013-01-25 Takeda Pharmaceuticals Co Kinase inhibitors
EP2223925A1 (en) * 2006-10-09 2010-09-01 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
CN101679408B (zh) * 2006-12-22 2016-04-27 Astex治疗学有限公司 作为fgfr抑制剂的双环杂环化合物
US8513276B2 (en) 2006-12-22 2013-08-20 Astex Therapeutics Limited Imidazo[1,2-a]pyridine compounds for use in treating cancer
MX2010000617A (es) 2007-07-17 2010-05-17 Plexxikon Inc Compuestos y metodos para modulacion de cinasa, e indicaciones de estos.
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) * 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
DE102008052943A1 (de) 2008-10-23 2010-04-29 Merck Patent Gmbh Azaindolderivate
EA022924B1 (ru) 2009-04-03 2016-03-31 Ф.Хоффманн-Ля Рош Аг ТВЁРДАЯ ФОРМА {3-[5-(4-ХЛОРФЕНИЛ)-1Н-ПИРРОЛО[2,3-b]ПИРИДИН-3-КАРБОНИЛ]-2,4-ДИФТОРФЕНИЛ}АМИДА ПРОПАН-1-СУЛЬФОНОВОЙ КИСЛОТЫ И ЕЁ ПРИМЕНЕНИЕ
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US20110030037A1 (en) * 2009-07-07 2011-02-03 Vadim Olshansky Zone migration in network access
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
NZ629615A (en) 2009-11-06 2016-01-29 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
SI2672967T1 (sl) 2011-02-07 2018-12-31 Plexxikon Inc. Spojine in postopki za kinazno modulacijo in indikacije zanjo
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US20150336948A1 (en) * 2012-05-29 2015-11-26 Merck Sharp & Dohme Corp. Isotopically Labeled Biaryl Urea Compounds
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US20140275082A1 (en) 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
GB201310464D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds
GB201310460D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3254843B2 (ja) * 1993-08-09 2002-02-12 三菱ウェルファーマ株式会社 新規縮合ヘテロ環誘導体
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
AU2002333524A1 (en) * 2001-09-11 2003-03-24 Glaxosmithkline K.K. Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
WO2003035621A1 (en) * 2001-10-22 2003-05-01 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
IL164187A0 (en) * 2002-03-28 2005-12-18 Eisai Co Ltd 7-Azaindole derivatives and pharmaceutical compositions containing the same
FR2878849B1 (fr) * 2004-12-06 2008-09-12 Aventis Pharma Sa Indoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
EP1877409A2 (fr) 2008-01-16
HRP20090494T1 (hr) 2009-10-31
EA200702329A1 (ru) 2008-02-28
MA29480B1 (fr) 2008-05-02
AU2006239105A1 (en) 2006-11-02
KR20080007229A (ko) 2008-01-17
SI1877409T1 (sl) 2009-12-31
ES2328629T3 (es) 2009-11-16
PT1877409E (pt) 2009-09-16
NO20075918L (no) 2007-11-19
TW200718701A (en) 2007-05-16
US7947706B2 (en) 2011-05-24
DE602006007337D1 (de) 2009-07-30
ATE433976T1 (de) 2009-07-15
RS51136B (sr) 2010-10-31
FR2884821A1 (fr) 2006-10-27
IL186523A0 (en) 2008-01-20
CN101166739A (zh) 2008-04-23
DK1877409T3 (da) 2009-10-05
PE20071420A1 (es) 2007-01-20
AR061386A1 (es) 2008-08-27
CY1109369T1 (el) 2014-07-02
CA2605744A1 (fr) 2006-11-02
PL1877409T3 (pl) 2009-12-31
JP2008539211A (ja) 2008-11-13
BRPI0613161A2 (pt) 2010-12-21
EP1877409B1 (fr) 2009-06-17
PA8671301A1 (es) 2006-12-07
FR2884821B1 (fr) 2007-07-06
EA012983B1 (ru) 2010-02-26
WO2006114520A2 (fr) 2006-11-02
WO2006114520A3 (fr) 2007-03-01
US20080139606A1 (en) 2008-06-12
CR9463A (es) 2008-02-21
DOP2006000096A (es) 2007-04-15
TNSN07360A1 (en) 2008-12-31
GT200600174A (es) 2006-12-26

Similar Documents

Publication Publication Date Title
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
TW200621777A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
TW200745084A (en) Novel compounds
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
UA98804C2 (ru) Катехоламиновые производные и фармацевтическая композиция на их основе
TW200745003A (en) Novel compounds
TW200630336A (en) Novel compounds
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
TW200621690A (en) Novel compounds
TW200738627A (en) Trialkylsilyl-indoles
TW200738659A (en) Novel compounds
TW200626593A (en) Novel compounds
TW200634007A (en) Substituted indoles, compositions containing them, production process and use
TW200833335A (en) New pyridine analogues
MX2009000768A (es) Lactamas macrociclicas.
TW200640857A (en) Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
MX2009003459A (es) Derivados de 2,3,3-trimetilciclopent-3-encarbaldehido utiles como odorantes.
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
TW200833371A (en) Process for solid formulations
TW200726758A (en) New pyridine analogues
TNSN07241A1 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof

Legal Events

Date Code Title Description
FG Grant or registration